These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2512186)

  • 21. [PUVA therapy: long-term degenerative effects. II. Study of ultrastructural changes in the skin induced by PUVA therapy].
    Torras H; Bombi JA
    Med Cutan Ibero Lat Am; 1987; 15(3):179-84. PubMed ID: 3312860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The risks of photochemotherapy (author's transl)].
    Stüttgen G; Kentsch V; Schalla W; Schneider L
    Z Hautkr; 1981 Nov; 56(21):1379-99. PubMed ID: 6458954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular side effects of PUVA-treated patients refusing eye sun protection.
    Calzavara-Pinton PG; Carlino A; Manfredi E; Semeraro F; Zane C; De Panfilis G
    Acta Derm Venereol Suppl (Stockh); 1994; 186():164-5. PubMed ID: 8073824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PUVA treatment and skin cancer: A follow-up study.
    Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
    Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
    Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
    Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis.
    Turjanmaa K; Salo H; Reunala T
    Acta Derm Venereol; 1985; 65(1):86-8. PubMed ID: 2578716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimising the risks of PUVA treatment.
    van Praag MC; Tseng LN; Mommaas AM; Boom BW; Vermeer BJ
    Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
    Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
    Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients.
    Lever LR; Farr PM
    Br J Dermatol; 1994 Aug; 131(2):215-9. PubMed ID: 7917985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T; Christophers E
    Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The Koebner phenomenon, a prognostic sign of PUVA therapy effectiveness in patients with psoriasis vulgaris--yes or no?].
    Matović L; Poljacki M; Duran V; Stojanović S; Subotić M
    Med Pregl; 1999; 52(11-12):437-40. PubMed ID: 10748764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on the PUVA (psoralen plus UVA) therapy of psoriasis. II. Histological findings of the treated skin (author's transl)].
    Kumakiri M; Ohnuki M; Koguchi K; Kato N; Tachibana N; Miura Y
    Nihon Hifuka Gakkai Zasshi; 1980 Oct; 90(11):1003-8. PubMed ID: 6970278
    [No Abstract]   [Full Text] [Related]  

  • 35. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
    Wolf P; Kreimer-Erlacher H; Seidl H; Bäck B; Soyer HP; Kerl H
    J Invest Dermatol; 2004 Jan; 122(1):190-200. PubMed ID: 14962108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actinic degeneration in association with long-term use of PUVA.
    Stern RS; Parrish JA; Fitzpatrick TB; Bleich HL
    J Invest Dermatol; 1985 Feb; 84(2):135-8. PubMed ID: 3968447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study.
    Cox NH; Jones SK; Downey DJ; Tuyp EJ; Jay JL; Moseley H; Mackie RM
    Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early dermato-pathological signs during bath-PUVA therapy.
    Piérard-Franchimont C; Nickels-Read D; Ben Mosbah T; Arrese Estrada J; Piérard GE
    J Pathol; 1990 Jul; 161(3):227-31. PubMed ID: 1975271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous carcinoma and PUVA lentigines in Thai patients treated with oral PUVA.
    Gritiyarangsan P; Sindhavananda J; Rungrairatanaroj P; Kullavanijaya P
    Photodermatol Photoimmunol Photomed; 1995 Aug; 11(4):174-7. PubMed ID: 8850252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for CD8+ cell increase in long-term PUVA-treated psoriatic patients after PUVA discontinuation.
    Borroni G; Zaccone C; Vignati G; Fietta A; Merlini C; Rabbiosi G
    Dermatology; 1992; 185(1):69-71. PubMed ID: 1638076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.